The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia.
Diabetes Res Clin Pract
; 208: 111126, 2024 Feb.
Article
en En
| MEDLINE
| ID: mdl-38311246
ABSTRACT
OBJECTIVE:
To examine the rate of gestational diabetes mellitus (GDM) prevalence before and during the COVID-19 pandemic.RESULTS:
Analysis revealed that GDM prevalence was significantly higher during the COVID-19 pandemic compared to pre-pandemic (8.59 % vs 7.77 %). The risk of GDM was 12 % higher during the pandemic vs. pre-pandemic (aRR = 1.12, 95 % CI 1.06, 1.19) and the aRD = 0.95 % (95 % CI 0.56 %, 1.33 %) adjusting for maternal age and substance use in pregnancy.CONCLUSIONS:
GDM rates in WV increased from the period directly before the COVID-19 pandemic to during the COVID-19 pandemic. More research is needed to understand the pathophysiological mechanisms of pandemics and pandemic-related risk factors for this observed association. Supporting pregnant individuals during such events is critical to both maternal and child health.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Diabetes Gestacional
/
COVID-19
Tipo de estudio:
Risk_factors_studies
Límite:
Child
/
Female
/
Humans
/
Pregnancy
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Diabetes Res Clin Pract
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2024
Tipo del documento:
Article